Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Entheon Biomedical Corp (OP: ENTBF ) 0.0700 -0.0100 (-12.50%) Streaming Delayed Price Updated: 1:05 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Entheon Biomedical Corp World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them August 30, 2022 The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... Via Benzinga Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill June 15, 2022 Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. Via Benzinga Largest Phase-1 DMT Study In The Netherlands, A Collaboration Between Entheon & Cybin June 07, 2022 Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has entered into an agreement to acquire a Phase 1 N,N-dimethyltryptamine (“DMT”)... Via Benzinga Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research June 01, 2022 Ehave, Inc. (OTC Pink: EHVVF) is a leading healthcare services and technology company focused on progressing psychedelics to therapeutics by engineering novel compounds and new treatment protocols for... Via Benzinga Entheon Biomedical Announces Non-Brokered Private Placement Financing April 05, 2022 Entheon Biomedical Corp. (OTCQB: ENTBF) announced anon-brokered private placement financingfor up to 30,000,000 Units at ... Via Benzinga Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th February 09, 2022 The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... Via Benzinga Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins February 07, 2022 This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. Via Benzinga Psychedelics Biotech Startup Launches Phase 1 Study On Ayahuasca's Active Ingredient February 03, 2022 Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics,... Via Benzinga Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments December 13, 2021 Image provided by Flickr The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... Via Benzinga Compass Pathways 2.0: A New Rally In Psychedelic Stocks? November 04, 2021 Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat? Via Talk Markets Topics Initial Public Offering Exposures Securities Market Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga Entheon Biomedical Acquires Lobo Genetics, Inc. in Bid to Strengthen Screening and Treatment Evaluation Tech for Psychedelics October 06, 2021 Image Provided by Wiki Commons Entheon Biomedical Corp. (OTCQB: ENTBF), the biotech research and development company focused on developing DMT-based treatments for addiction and... Via Benzinga There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected August 02, 2021 Last week in Psychedelics: Via Benzinga Entheon Biomedical Corp. Strengthens Its Psychedelic-Assisted Protocols Through Acquisition Of Lobo Genetics July 30, 2021 Psychedelics biotech company Entheon Biomedical Corp. (CSE:ENBI Via Benzinga How To Invest In "Magic Mushrooms" (Psychedelics) July 09, 2021 A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest. Via Talk Markets Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies July 07, 2021 This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Ps... Via Benzinga Psyched: Atai Life Sciences Hits Nasdaq, Canada To Fund Ketamine Trials, Mydecine Launches AI Drug-Discovery Platform June 21, 2021 Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence What Do You Really Know About Psychedelics And Psychedelics Stocks? June 08, 2021 According to a new poll conducted by Hill-HarrisX, 65% of registered voters say psychedelic substances do not have medical use. That... Via Benzinga Video: The Psychedelics Market With Entheon Biomedical, MagicMed, Natan Ponieman May 06, 2021 Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Patrick&... Via Benzinga Topics Cannabis Exposures Cannabis Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
